Peer-reviewed veterinary case report
Treatment of equine sarcoids using recombinant poxviruses expressing feline interleukin-2.
- Journal:
- Veterinary dermatology
- Year:
- 2021
- Authors:
- Loschelder-Ostrowski, Johanna et al.
- Affiliation:
- Clinic for Horses · Germany
- Species:
- horse
Plain-English summary
In a study involving twenty horses, all around eight years old, researchers tested a new treatment for equine sarcoids, which are skin tumors. They injected a special virus that carries a protein called feline interleukin-2, which is known to help the immune system fight tumors. After two injections, 40% of the horses had complete shrinkage of their tumors, while 10% had some improvement, but 25% showed no change or worsening of their condition. The treatment appeared safe, with only one horse experiencing a mild fever that went away on its own. Overall, the treatment worked for half of the horses, but more research is needed to confirm these results and develop a standard treatment plan.
Abstract
BACKGROUND: Interleukin (IL)-2 stimulates antitumour immunity and is successfully used for the treatment of different neoplasias. HYPOTHESIS/OBJECTIVES: Canarypox virus locally expressing feline IL-2 is safe and can be used to treat equine sarcoids. ANIMALS: Twenty horses of different breeds with a median age of eight years (interquartile range 6.0-13.3 years) and a total number of 59 sarcoids were included in the study. METHODS: In this prospective clinical trial, sarcoids were injected twice seven days apart, with a recombinant canarypox virus expressing feline IL-2. Complete blood counts (CBC) and fibrinogen levels were measured before treatment and on days 1, 2, 7 and 8. RESULTS: Complete regression was achieved in eight horses (40%) and partial regression in two horses (10%). No change in sarcoid size was observed in two horses (10%) and the disease progressed in five horses (25%). Sarcoids of three horses (15%) showed initial response followed by tumour growth. There were no significant changes in CBC and fibrinogen levels after either injection. One horse developed a mild fever the day after each injection, which subsided without treatment the following day. CONCLUSIONS: Treatment of equine sarcoids with recombinant canarypox virus expressing feline IL-2 seems to be a safe therapy option. Although the expression of IL-2 after vector injection and its biological activity in horses were not proven in this study, the treatment resulted in regression and partial regression in 50% of the cases. Further studies are necessary to verify these findings and to establish a treatment protocol.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/33728715/